Please Wait.....
Report
Pharmacy Management System Market Forecast to 2030
Market Report I 2023-03-07 I 110 Pages I Market Research Future
Pharmacy Management System Market Forecast to 2030
Market Dynamics
The pharmacy management system market is expected to register a healthy CAGR of 10.12% by 2030. The system utilized in a pharmacy to assist with computerizing the pharmacy work process is known as pharmacy management programming. This incorporates assessing doctor medicines and getting ready meds, and stock management. The worldwide market development of the pharmacy management system is credited to the ascent in the number of vital drives, and benefits related to pharmacy management systems, and the weight on drug specialists because of the rising number of remedies. Besides, the rising interest in pharmacy management systems in arising economies gives learning experiences to the market from now on. Notwithstanding, complex highlights, for example, vendor security could obstruct the market's development in the conjecture period.
Pharmacy management systems are huge devices with exceptionally powerful and user-friendly management benefits that help drug specialists in overseeing assignments, including stock management, administering prescriptions, and deals capability. These systems additionally permit drug specialists to offer proficient consideration in light of patient necessities. A rising number of vital drives as dispatches, consolidations and acquisitions, coordinated efforts, and joint endeavors are driving the pharmacy management system market.
Segment Overview
By Solution Type, the market is partitioned into Pharmacy Stock Management Software, Pharmacy Information Management Systems, Pharmacy Intensifying Software Systems, Pharmacy Advantage Management, Pharmacy Income Cycle Management System, and Others.
By Component, the fragment separates the market into Software, Hardware, and Services. By Deployment Mode the market is bifurcated into On-Premises and Cloud/Electronic. By End Users, the worldwide market is bifurcated into Ongoing Drug stores and short-term Drug stores. The short-term fragment is further sub-sectioned into quick track centers and emergency clinic retail settings.
Regional Analysis
Americas is expected to register a significant CAGR of 10.29% by the end of 2030. This is credited to expanding mechanical headway, for example, mechanized termination date following, which assists with lessening burn through and saves staff time and so on. As per the American School of Clinical Pharmacy, around 5 billion remedies will be apportioned by 2021, which will build drug specialists' weight; thus, the reception of mechanized arrangements in work process management is normal.
The Europe pharmacy management system market is segregated among France, Germany, the UK, Switzerland, Netherlands, Belgium, Russia, Spain, Italy, Austria, and the remainder of Europe. The advantages presented by pharmacy management empower drug specialists to oversee medication advantageously and bother-free, right from their PC or cell phone. Moreover, rising web infiltration across the region, further developing digitalization of medical care administrations, and the developing number of educated drug specialists are additionally supporting the market development.
Key Players
DataScan Pharmacy (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Epicor Software Corporation (US) GlobeMed Group (Lebanon), LS Retail EHF (Iceland), McKesson Corporation (US), Liberty Software, Inc. (US), MedHOK, Inc. (US), Octal IT Solution LLP (India), ScriptPro LLC (US), Clanwilliam Health (Ireland), Safecare Technology (UAE), Mobile MedSoft (US), and Health Business Systems, Inc. (US).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE SYSTEM
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISE IN THE NUMBER OF STRATEGIC INITIATIVES
4.2.2 BENEFITS ASSOCIATED WITH PHARMACY MANAGEMENT SYSTEMS
4.2.3 BURDEN ON PHARMACISTS DUE TO INCREASING NUMBER OF PRESCRIPTIONS
4.3 RESTRAINTS
4.3.1 COMPLEX FEATURES SUCH AS VENDOR LOCK-IN
4.4 OPPORTUNITIES
4.4.1 INCREASING DEMAND FOR PHARMACY MANAGEMENT SYSTEMS IN EMERGING ECONOMIES
4.5 CHALLENGES
4.5.1 UNAVAILABILITY OF TRAINED PROFESSIONALS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 INPUTS
5.1.2 SOFTWARE DEVELOPMENT PROCESSES
5.1.3 OUTPUT
5.1.4 MARKETING AND DISTRIBUTION
5.1.5 POST-SELLING SERVICES
5.1.5.1 SOFTWARE MAINTENANCE SERVICES & AGREEMENTS
5.1.5.2 TRAINING & CERTIFICATIONS
5.1.5.3 SUPPORT: TECHNICAL & GRIEVANCE AID
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE PHARMACY MANAGEMENT SYSTEM MARKET
6 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE
6.1 OVERVIEW
6.2 PHARMACY INVENTORY MANAGEMENT SYSTEM
6.3 PHARMACY DATA MANAGEMENT SYSTEM
6.4 PHARMACY COMPOUNDING SOFTWARE SYSTEM
6.5 PHARMACY BENEFITS MANAGEMENT SYSTEM
6.6 PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM
6.7 OTHERS
7 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SOFTWARE
7.3 HARDWARE
7.4 SERVICES
8 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE
8.1 OVERVIEW
8.2 CLOUD/WEB-BASED
8.3 ON-PREMISE
9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER
9.1 OVERVIEW
9.2 INPATIENT PHARMACIES
9.3 OUTPATIENT PHARMACIES
10 PHARMACY MANAGEMENT SYSTEMS, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 NETHERLANDS
10.3.1.7 SWITZERLAND
10.3.1.8 BELGIUM
10.3.1.9 AUSTRIA
10.3.1.10 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 TAIWAN
10.4.7 NEW ZEALAND
10.4.8 THAILAND
10.4.9 PHILIPPINES
10.4.10 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11.6.2 MERGER & ACQUISITIONS
11.6.3 AGREEMENT/MARKETING STRATEGIES
12 COMPANY PROFILES
12.1 ALLSCRIPTS HEALTHCARE, LLC
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 CERNER CORPORATION
12.2.1 COMPANY OVERVIEW
12.2.2 PRODUCTS OFFERED
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 DATASCAN PHARMACY
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIES
12.4 EPICOR SOFTWARE CORPORATION
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 GLOBEMED GROUP
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 LIBERTY SOFTWARE, INC.
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 LS RETAIL EHF
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 MCKESSON CORPORATION
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 MEDHOK, INC.
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 OCTAL IT SOLUTION LLP
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
12.11 SAFECARE TECHNOLOGY
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCTS OFFERED
12.11.4 KEY DEVELOPMENTS
12.11.5 KEY STRATEGIES
12.12 SCRIPTPRO LLC
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 PRODUCTS OFFERED
12.12.4 KEY DEVELOPMENTS
12.12.5 KEY STRATEGIES
12.13 CLANWILLIAM HEALTH
12.13.1 COMPANY OVERVIEW
12.13.2 FINANCIAL OVERVIEW
12.13.3 PRODUCTS OFFERED
12.13.4 KEY DEVELOPMENTS
12.13.5 KEY STRATEGIES
12.14 MOBILE MEDSOFT
12.14.1 COMPANY OVERVIEW
12.14.2 FINANCIAL OVERVIEW
12.14.3 PRODUCTS OFFERED
12.14.4 KEY DEVELOPMENTS
12.14.5 KEY STRATEGIES
12.15 HEALTH BUSINESS SYSTEMS, INC.
12.15.1 COMPANY OVERVIEW
12.15.2 FINANCIAL OVERVIEW
12.15.3 PRODUCTS OFFERED
12.15.4 KEY DEVELOPMENTS
12.15.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 4 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY INVENTORY MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 5 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY DATA MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 6 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY COMPOUNDING SOFTWARE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 7 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMA PHARMACY BENEFITS MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 8 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 15 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR CLOUD/WEB-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 16 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 18 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 23 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 25 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 26 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 27 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 28 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 29 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 30 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 32 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 33 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 34 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 35 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 36 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 37 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 38 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 39 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 40 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 41 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 42 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 43 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 44 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 45 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 46 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 47 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 48 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 49 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 50 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 51 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 52 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 53 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 54 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 55 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 56 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 58 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 59 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 60 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 61 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 62 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 63 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 64 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 66 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 67 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 68 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 69 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 70 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 71 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 72 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 73 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 74 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 75 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 76 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 77 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 78 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 79 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 80 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 81 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 82 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 83 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 84 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 85 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 86 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 87 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 88 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 89 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 90 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 91 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 92 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 93 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 94 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 95 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 96 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 97 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 98 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 99 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 100 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 101 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 102 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 103 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 104 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 105 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 106 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 107 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 108 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 109 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 110 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 111 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 112 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 113 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 114 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 115 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 116 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 117 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 118 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 119 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 120 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 121 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 122 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 123 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 124 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 125 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 126 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 127 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 128 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
TABLE 129 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 131 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 133 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 136 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 137 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 138 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 139 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 140 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 141 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 143 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 144 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 145 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 146 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 147 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 148 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 149 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 150 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 151 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 152 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 153 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 155 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 156 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 157 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 158 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 159 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 161 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 162 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 163 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 164 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 165 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 167 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 168 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 169 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 170 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 171 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 172 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 173 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 174 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 175 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 176 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 179 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 180 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 181 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 182 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 184 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 185 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 186 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 187 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 188 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 189 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 190 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 191 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 192 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 193 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 194 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 195 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 201 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 203 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 204 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 205 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 206 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 207 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 209 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
TABLE 210 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 211 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 212 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
TABLE 213 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
TABLE 215 MAJOR PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
TABLE 216 MOST ACTIVE PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
TABLE 217 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 218 MERGER & ACQUISITIONS
TABLE 219 AGREEMENT/MARKETING STRATEGIES
TABLE 220 ALLSCRIPTS HEALTHCARE, LLC: SERVICES OFFERED
TABLE 221 ALLSCRIPTS HEALTHCARE, LLC: KEY DEVELOPMENTS
TABLE 222 CERNER CORPORATION: PRODUCTS OFFERED
TABLE 223 DATASCAN PHARMACY: PRODUCTS OFFERED
TABLE 224 EPICOR SOFTWARE CORPORATION: PRODUCTS OFFERED
TABLE 225 GLOBEMED GROUP: PRODUCTS OFFERED
TABLE 226 LIBERTY SOFTWARE, INC.: PRODUCTS OFFERED
TABLE 227 LS RETAIL EHF.: PRODUCTS OFFERED
TABLE 228 MCKESSON CORPORATION: PRODUCTS OFFERED
TABLE 229 MCKESSON CORPORATION: KEY DEVELOPMENTS
TABLE 230 MEDHOK, INC.: PRODUCTS OFFERED
TABLE 231 OCTAL IT SOLUTION LLP.: PRODUCTS OFFERED
TABLE 232 SAFECARE TECHNOLOGY: PRODUCTS OFFERED
TABLE 233 SCRIPTPRO LLC: PRODUCTS OFFERED
TABLE 234 CLANWILLIAM HEALTH: PRODUCTS OFFERED
TABLE 235 CLANWILLIAM HEALTH: KEY DEVELOPMENTS
TABLE 236 MOBILE MEDSOFT: PRODUCTS OFFERED
TABLE 237 HEALTHCARE BUSINESS SYSTEMS, INC.: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN: GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2021 & 2030 (USD MILLION)
FIGURE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2021 & 2030 (USD MILLION)
FIGURE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2021 & 2030 (USD MILLION)
FIGURE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2021 & 2030 (USD MILLION)
FIGURE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET SHARE (%), BY REGION, 2021
FIGURE 14 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 15 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 16 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 17 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 18 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS SHARE, BY COUNTRY 2021 (%)
FIGURE 19 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS SHARE, BY COUNTRY 2021 (%)
FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 22 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET: COMPETITIVE LANDSCAPE
FIGURE 23 ALLSCRIPTS HEALTHCARE, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ALLSCRIPTS HEALTHCARE, LLC: SWOT ANALYSIS
FIGURE 25 CERNER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 CERNER CORPORATION: SWOT ANALYSIS
FIGURE 27 EPICOR SOFTWARE CORPORATION: SWOT ANALYSIS
FIGURE 28 GLOBEMED GROUP: SWOT ANALYSIS
FIGURE 29 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 MCKESSON CORPORATION: SWOT ANALYSIS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security